Location History:
- Munchen, DE (1999)
- Mannheim, DE (1991 - 2001)
Company Filing History:
11 out of 1,164 
1 out of 29 
1 out of 3 Years Active: 1991-2001
Title: Innovations in Thromboembolic Treatment by Ulrich Martin
Introduction
Ulrich Martin is a prominent inventor based in Mannheim, Germany. He has made significant contributions to the field of thromboembolic treatment, holding a total of 12 patents. His work focuses on therapeutic approaches that aim to improve patient outcomes in the management of thromboembolic conditions.
Latest Patents
One of Ulrich Martin's latest patents is a method for treating thromboembolic conditions by inhibiting reocclusion through the use of multiple bolus administration of thrombolytically active proteins. This innovative therapy discusses the use of thrombolytically active proteins that inhibit reocclusion in patients. The proteins are administered in two or more boli, enhancing their effectiveness. Another notable invention relates to the use of thromboembolic proteins that contain, as their only structural portion effecting thrombolytic activity, the protease domain of human tissue-type plasminogen activator. These derivatives demonstrate reduced side effects, such as a decrease in bleeding, while showcasing remarkable in vivo efficacy. The surprising effect of these proteins, given their in vitro properties, highlights the potential for improved therapeutic options.
Career Highlights
Throughout his career, Ulrich Martin has worked with notable companies, including Boehringer Mannheim GmbH and Protein Design Labs, Inc. His experience in these organizations has contributed to his expertise in the development of innovative treatments for thromboembolic conditions.
Collaborations
Ulrich has collaborated with esteemed colleagues, including Stephan Fischer and Anne Stern. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in the field.
Conclusion
Ulrich Martin's contributions to thromboembolic treatment through his innovative patents and collaborations have significantly impacted the medical field. His work continues to pave the way for new therapeutic approaches that enhance patient care and outcomes.